Breast cancer deaths in the US continue to fall, but new report
WEB2 days ago · The study, published Tuesday in CA: A Cancer Journal for Clinicians, found some good news: The overall breast cancer death rate in the US dropped about 44% between 1989 and 2022, which translates ...
Breast Cancer Incidence Still Rises and Death Rate Still Declines
WEB1 day ago · A new American Cancer Society (ACS) report finds that the incidence of breast cancer in women has continued to increase, rising by 1% a year during 2012 to 2021, for all women combined. These cases are largely confined to localized-stage cancers, which have not spread from the breast, and hormone receptor-positive disease (either estrogen positive or progesterone positive), the most common ...
Breast Cancer Continues to Rise Among Younger Women, Study …
WEB2 days ago · Breast cancer incidence rose by 1 percent a year overall from 2012 to 2021. But women in their 20s, 30s and 40s experienced a 1.4 percent annual increase in incidence, while the increase among ...
US Breast Cancer Cases Rising Despite Declining Death Rates, …
WEB1 day ago · Breast cancer rates are rising sharply in the United States, driven by increases among younger women and Asian Americans, a study said Tuesday.. The biennial report by the American Cancer Society found the number of cases grew by one percent each year from 2012 to 2021, even as the overall death rate continued its historic trend of decline, falling 44 percent from 1989 to 2022.
Breast Cancer News - ScienceDaily
WEB2 days ago · Breast cancer research including information on breast cancer symptoms, prevention strategies, screening techniques, and new breast cancer treatments.
New study finds triple-negative breast cancer tumors with an …
WEBApr 25, 2024 · A new multicenter, international study suggests that people who have early-stage triple-negative breast cancer (TNBC) and high levels of immune cells within their tumors may have a lower risk of recurrence and better survival rates even when not treated with chemotherapy.
Breast cancer treatment: Drug Kisqali approval expanded for ... - NBC News
WEBSep 17, 2024 · The FDA expanded the approval of Kisqali, a drug for metastatic breast cancer, to treat patients with earlier stage cancer, Novartis said. The drug was found to reduce the risk of a patient's...
Estrogen a more powerful breast cancer culprit than we realized
WEBMay 17, 2023 · A Harvard Medical School study shows the sex hormone estrogen — thus far thought to be only a fuel for breast cancer growth — can directly cause tumor-driving genomic rearrangements.
Breast Cancer Drug Trial Results in ‘Unheard-Of’ Survival
WEBJun 7, 2022 · The clinical trial, sponsored by the pharmaceutical companies Daiichi Sankyo and AstraZeneca and led by Dr. Shanu Modi of Memorial Sloan Kettering Cancer Center, involved 557 patients with...
Targeted therapy shows benefit for people with advanced breast cancer ...
WEBDec 8, 2022 · CNN — An experimental treatment shows promise for people with the most common form of advanced-stage breast cancer, according to results from a Phase 3 clinical trial. The details of the trial...